Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1

Conditions

Ovarian Neoplasms 4Lung Neoplasms 3Gastrointestinal Neoplasms 3Stomach Neoplasms 2Neoplasms 2Esophageal Neoplasms 2Urinary Bladder Neoplasms 1Sarcoma 1Prostatic Neoplasms 1Pituitary Neoplasms 1Peritoneal Neoplasms 1Pelvic Neoplasms 1Osteosarcoma 1Head and Neck Neoplasms 1Endometrial Neoplasms 1Carcinoma, Renal Cell 1Appendiceal Neoplasms 1

Interventions

Radiotherapy 4Surveys and Questionnaires 3Specimen Handling 2Iohexol 2Gemcitabine 2spartalizumab 1sodium thiosulfate 1serotonin adipinate 1liposomal doxorubicin 1X-Rays 1Watchful Waiting 1Vorinostat 1Surgical Procedures, Operative 1Sunitinib 1Solutions 1Serotonin 1Saline Solution 1Re-Irradiation 1Radiotherapy, Image-Guided 1Radiosurgery 1Probiotics 1Platinum 1Particle Accelerators 1Pafolacianine 1Paclitaxel 1Magnetic Resonance Spectroscopy 1Magnetic Resonance Imaging 1Lidocaine 1Ketamine 1Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pelvic Neoplasms × Pafolacianine × Clear all
NCT06915727 2026-04-01

An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors

Mayo Clinic

Phase 3 Recruiting
20 enrolled
GynecologicHead & Neck

Head and Neck Neoplasms, Pelvic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡